DIABIO Share Price Performance
SEK 0.004
-0.01 (-73.33%)
Price SEK 0.004
Share Pricen/a
Diagonal Bio AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
DIABIO Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Diagonal Bio AB (publ) Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -0.0058
- 68.77%
- -677.89%
- 0%
About DIABIO
- Founded
- 2020
- Employees
- 4
- CEO
- WebsiteView website
Diagonal Bio AB (publ) provides a point-of-care testing system for genetic markers that detects viruses, bacteria and fungi in Sweden. The company offers LAMPlify, a system used to identify the presence of specific genetic markers, such as fungi, viruses, or bacteria. It is also involved in the development of PANVIRAL, a universal in vitro diagnostic system, that offers the potential for rapid and accurate point-of-care diagnoses in various settings, such as doctor’s office, surgery, mobile clinics, hospital bedsides, and workplaces and airports. The company was incorporated in 2020 and is based in Lund, Sweden.
